Veracyte Names Kevin Haas as Chief Development and Technology Officer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a number one most cancers diagnostics firm, introduced at present that Kevin Haas, Ph.D., has been appointed Chief Development and Technology Officer,…